Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 19 (4), 675-690
- https://doi.org/10.1016/s0149-2918(97)80092-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmaticsEuropean Respiratory Journal, 1994
- Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthmaJournal of Allergy and Clinical Immunology, 1992
- Cytokines in symptomatic asthma airwaysJournal of Allergy and Clinical Immunology, 1992
- Role of Leukotrienes in Exercise-induced Asthma: Inhibitory Effect of ICI 204219, a Potent Leukotriene D4Receptor AntagonistAmerican Review of Respiratory Disease, 1992
- Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic SubjectsAmerican Review of Respiratory Disease, 1991
- Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.JCI Insight, 1991
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Mucosal Inflammation in AsthmaAmerican Review of Respiratory Disease, 1990
- Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseasesJournal of Allergy and Clinical Immunology, 1989
- URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITISThe Lancet, 1989